I wish you luck. I'll stick with the stock for now. I don't think you will see any earnings until the end of the year. They just launched the sale of morphine to add to the earnings but you won't see that for a least a quarter or two. I'm surprised the stock has not recovered since all 3 approvals will add to their earnings. Very strange climate right now.